Guided Therapeutics, Inc. (OTCMKTS:GTHP) Sees Large Drop in Short Interest

Guided Therapeutics, Inc. (OTCMKTS:GTHP) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a drop of 96.7% from the October 31st total of 12,000 shares. Based on an average daily trading volume, of 9,500 shares, the short-interest ratio is currently 0.0 days.

Guided Therapeutics Stock Performance

Guided Therapeutics stock traded down $0.03 during midday trading on Wednesday, hitting $0.16. 1,969 shares of the company were exchanged, compared to its average volume of 21,591. The business has a fifty day simple moving average of $0.17 and a two-hundred day simple moving average of $0.14. The firm has a market capitalization of $9.76 million, a PE ratio of -5.33 and a beta of 0.51. Guided Therapeutics has a fifty-two week low of $0.06 and a fifty-two week high of $0.25.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.